149 related articles for article (PubMed ID: 32605304)
1. Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats.
Karbownik A; Szkutnik-Fiedler D; Czyrski A; Kostewicz N; Kaczmarska P; Bekier M; Stanisławiak-Rudowicz J; Karaźniewicz-Łada M; Wolc A; Główka F; Grześkowiak E; Szałek E
Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32605304
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic Drug Interaction Study of Sorafenib and Morphine in Rats.
Karbownik A; Szkutnik-Fiedler D; Grabowski T; Wolc A; Stanisławiak-Rudowicz J; Jaźwiec R; Grześkowiak E; Szałek E
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959453
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic Interactions between Canagliflozin and Sorafenib or Lenvatinib in Rats.
Cui Y; Li Y; Guo C; Li Y; Ma Y; Dong Z
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080187
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Interaction of Green Rooibos Extract With Atorvastatin and Metformin in Rats.
Patel O; Muller CJF; Joubert E; Rosenkranz B; Taylor MJC; Louw J; Awortwe C
Front Pharmacol; 2019; 10():1243. PubMed ID: 31708777
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets.
Ghim JL; Phuong NTT; Kim MJ; Kim EJ; Song GS; Ahn S; Shin JG; Kim EY
Drug Des Devel Ther; 2019; 13():1623-1632. PubMed ID: 31190741
[No Abstract] [Full Text] [Related]
6. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine.
Shi R; Xu Z; Xu X; Jin J; Zhao Y; Wang T; Li Y; Ma Y
Eur J Pharm Sci; 2019 Jan; 127():282-290. PubMed ID: 30428337
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects.
Yamazaki T; Desai A; Goldwater R; Han D; Lasseter KC; Howieson C; Akhtar S; Kowalski D; Lademacher C; Rammelsberg D; Townsend R
Clin Pharmacol Drug Dev; 2017 Jan; 6(1):66-75. PubMed ID: 27273004
[TBL] [Abstract][Full Text] [Related]
8. Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale.
Casadei Gardini A; Faloppi L; De Matteis S; Foschi FG; Silvestris N; Tovoli F; Palmieri V; Marisi G; Brunetti O; Vespasiani-Gentilucci U; Perrone G; Valgiusti M; Granato AM; Ercolani G; Negrini G; Tamburini E; Aprile G; Passardi A; Santini D; Cascinu S; Frassineti GL; Scartozzi M
Eur J Cancer; 2017 Nov; 86():106-114. PubMed ID: 28985579
[TBL] [Abstract][Full Text] [Related]
9. Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate).
Ceckova M; Reznicek J; Deutsch B; Fromm MF; Staud F
PLoS One; 2018; 13(8):e0202706. PubMed ID: 30114293
[TBL] [Abstract][Full Text] [Related]
10. Multidrug and toxin extrusion protein 1-mediated interaction of metformin and Scutellariae radix in rats.
Yim S; You BH; Chae HS; Chin YW; Kim H; Choi HS; Choi YH
Xenobiotica; 2017 Nov; 47(11):998-1007. PubMed ID: 27817253
[TBL] [Abstract][Full Text] [Related]
11. Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects.
Hausner H; Derving Karsbøl J; Holst AG; Jacobsen JB; Wagner FD; Golor G; Anderson TW
Clin Pharmacokinet; 2017 Nov; 56(11):1391-1401. PubMed ID: 28349387
[TBL] [Abstract][Full Text] [Related]
12. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin.
Mazzu AL; Lasseter KC; Shamblen EC; Agarwal V; Lettieri J; Sundaresen P
Clin Pharmacol Ther; 2000 Oct; 68(4):391-400. PubMed ID: 11061579
[TBL] [Abstract][Full Text] [Related]
13. Monitoring Serum Levels of Sorafenib and Its N-Oxide Is Essential for Long-Term Sorafenib Treatment of Patients with Hepatocellular Carcinoma.
Shimada M; Okawa H; Kondo Y; Maejima T; Kataoka Y; Hisamichi K; Maekawa M; Matsuura M; Jin Y; Mori M; Suzuki H; Shimosegawa T; Mano N
Tohoku J Exp Med; 2015 Nov; 237(3):173-82. PubMed ID: 26477611
[TBL] [Abstract][Full Text] [Related]
14. High-Dose Metformin May Increase the Concentration of Atorvastatin in the Liver by Inhibition of Multidrug Resistance-Associated Protein 2.
Shin E; Shin N; Oh JH; Lee YJ
J Pharm Sci; 2017 Apr; 106(4):961-967. PubMed ID: 27964938
[TBL] [Abstract][Full Text] [Related]
15. Liquid chromatography tandem mass spectrometry for the simultaneous determination of metformin and pioglitazone in rat plasma: Application to pharmacokinetic and drug-drug interaction studies.
Elgawish MS; Nasser S; Salama I; Abbas AM; Mostafa SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():47-57. PubMed ID: 31177048
[TBL] [Abstract][Full Text] [Related]
16. Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib.
Casadei Gardini A; Marisi G; Scarpi E; Scartozzi M; Faloppi L; Silvestris N; Masi G; Vivaldi C; Brunetti O; Tamberi S; Foschi FG; Tamburini E; Tenti E; Ricca Rosellini S; Ulivi P; Cascinu S; Nanni O; Frassineti GL
Expert Opin Pharmacother; 2015; 16(18):2719-25. PubMed ID: 26513009
[TBL] [Abstract][Full Text] [Related]
17. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
Müller F; Pontones CA; Renner B; Mieth M; Hoier E; Auge D; Maas R; Zolk O; Fromm MF
Eur J Clin Pharmacol; 2015 Jan; 71(1):85-94. PubMed ID: 25552403
[TBL] [Abstract][Full Text] [Related]
18. The Influence of Paracetamol on the Penetration of Sorafenib and Sorafenib N-Oxide Through the Blood-Brain Barrier in Rats.
Karbownik A; Stanisławiak-Rudowicz J; Stachowiak A; Romański M; Grześkowiak E; Szałek E
Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):801-808. PubMed ID: 32776310
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
Jacobson TA
Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of the biochemical basis for a clinical drug-drug interaction between atorvastatin and 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methyl benzoic acid (CP-778875), a subtype selective agonist of the peroxisome proliferator-activated receptor alpha.
Kalgutkar AS; Chen D; Varma MV; Feng B; Terra SG; Scialis RJ; Rotter CJ; Frederick KS; West MA; Goosen TC; Gosset JR; Walsky RL; Francone OL
Xenobiotica; 2013 Nov; 43(11):963-72. PubMed ID: 23631744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
